International Mother Language Day, 21 February 2026

Feb 17, 2026 | Non classé

Languages shape how people learn, connect, and participate in society. On 21 February 2026, International Mother Language Day highlights the importance of linguistic diversity and inclusion under the theme “Youth Voices on Multilingual Education”.

In a rapidly changing world shaped by migration and technology, multilingualism is increasingly recognised as both a social reality and a powerful educational approach. Young people are playing a critical role by revitalising languages, creating digital content, and advocating for education systems that reflect the linguistic diversity of their communities.

Yet significant gaps remain. Around 40% of learners worldwide still lack access to education in a language they understand best, disproportionately affecting indigenous, migrant, and minority youth. At the same time, many languages are at risk of disappearing, with only a small fraction represented in education systems or the digital space.

International Mother Language Day, proclaimed by UNESCO and adopted by the United Nations General Assembly, underscores the role of multilingual education in promoting inclusion, preserving cultural heritage, and advancing the Sustainable Development Goals.

As a team of almost 50 professionals working across 18 countries and four continents, Pharmalys embraces linguistic and cultural diversity. Our colleagues speak a wide range of languages and bring deep local understanding to the contexts in which we operate. This diversity enables us to adapt to different environments and cultures with respect and agility, ensuring that our work remains responsive, inclusive, and grounded in local realities.

On International Mother Language Day, we reaffirm our commitment to collaboration, cultural awareness, and evidence-based approaches that support equitable access and sustainable development worldwide.

Source: United Nations, International Mother Language Day 21 February, https://www.un.org/en/observances/mother-language-day

Pharmalys corporate social responsibility commitments

Pharmalys corporate social responsibility commitments

Pharmalys’ approach to corporate social responsibility reflects its long-standing commitment to advancing clinical research while contributing to sustainable and inclusive healthcare systems, particularly across the African continent. Structured around three core...

A recap from the first Pharmalys Voice of 2026

A recap from the first Pharmalys Voice of 2026

On 26 March 26 2026, Pharmalys held its first Pharmalys Voice meeting of the year, bringing together colleagues from across the company for an engaging and interactive virtual session. With a mix of insightful presentations, lively discussions and moments of fun, the...

Women’s economic power benefits everyone

Women’s economic power benefits everyone

Gender equality is a core challenge to be met. More than 95% of women worldwide live in economies that do not provide full legal equality. Even in economies that have modernised their laws, women still face constraints that limit the work they can do, the businesses...

Microplastics and human health: A growing public health concern

Microplastics and human health: A growing public health concern

Developed following the 19th century Industrial Revolution, plastics are synthetic or semi-synthetic polymers, categorised according to the chemical composition of their primary polymer and any side chains. These include acrylics, polyesters, silicones, polyethylenes...

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

A successful GCLP Audit at Institut Pasteur de Dakar, Senegal

Jeanette Young’s unit at Pharmalys plays a crucial role in advancing global excellence in Good Clinical Laboratory Practice (GCLP) through the delivery of highly specialised ad hoc services, including tailored GCLP trainings and comprehensive gap analyses for...

Delivering excellence under complexity: Lessons learnt from Africa

Delivering excellence under complexity: Lessons learnt from Africa

Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the execution of numerous clinical trials (CTs) in Africa. Across these projects,...